Product
Virus Specific T cells
1 clinical trial
2 indications
Indication
Viral infectionsIndication
Bone Marrow Transplant InfectionClinical trial
Novel Antigens Targeted by ex Vivo Expanded T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell TransplantationStatus: Active (not recruiting), Estimated PCD: 2024-10-01